Drug Type Prophylactic vaccine |
Synonyms Asudemotide, S-288310/S-488410, S-488310/S-288310 + [1] |
Target |
Mechanism DEPDC1 inhibitors(DEP domain containing 1 inhibitors), KIF20B inhibitors(kinesin family member 20B inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Esophageal Carcinoma | Phase 3 | JP | 05 Mar 2015 | |
Non-Small Cell Lung Cancer | Phase 2 | JP | 01 Mar 2015 | |
Bladder Cancer | Phase 2 | JP | - | 26 Jan 2014 |
Phase 2 | Metastatic urothelial carcinoma Maintenance | 81 | ecsttvrxwg(cmadfvpvry) = jlaqyvhimp owznzfusab (trstofjfvz ) View more | - | 02 Mar 2021 | ||
(Observation group) | uejnjllnyu(gtkoapzvjt) = vasjzarjql qslzqugoya (vvnjvixkxa ) View more | ||||||
Phase 1 | 15 | ovyedopifq(znnahdiyxn) = iwzkiwlxch bzrqqxymfn (nxeqdbgwxb ) View more | - | 20 Oct 2018 |